PuSH - Publication Server of Helmholtz Zentrum München

29 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Gregson, J.* et al.: Cardiovascular risk factors are associated with venous thromboembolism. JAMA Cardiol. 4, 163-173 (2019)
2.
Pennells, L.* et al.: Equalization of four cardiovascular risk algorithms after systematic recalibration: Individual-participant meta-analysis of 86 prospective studies. Eur. Heart J. 40, 621-631 (2019)
3.
Kroeger, J.* et al.: Circulating fetuin - A and risk of type 2 diabetes : A mendelian randomization analysis. Diabetes 67, 1200-1205 (2018)
4.
Wood, A.M.* et al.: Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 391, 1513-1523 (2018)
5.
Ezzati, M.* et al.: Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627-2642 (2017)
6.
Holzinger, E.R.* et al.: Discovery and replication of SNP-SNP interactions for quantitative lipid traits in over 60,000 individuals. BioData Min. 10:25 (2017)
7.
Scott, R.A.* et al.: An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888-2902 (2017)
8.
NCD Risk Factors Collaboration et al.: Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387, 1377-1396 (2016)
9.
Fuchsberger, C.* et al.: The genetic architecture of type 2 diabetes. Nature 536, 41-47 (2016)
10.
Scott, R.A.* et al.: A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Sci. Transl. Med. 8:341ra76 (2016)
11.
van der Laan, S.W.* et al.: Cystatin C and cardiovascular disease: A mendelian randomization study. J. Am. Coll. Cardiol. 68, 934-945 (2016)
12.
Emerging Risk Factors Collaboration (di Angelantonio, E.* ; Kaptoge, S.* ; Wormser, D.* ; Willeit, P.* ; Butterworth, A.S.* ; Bansal, N.* ; O'Keeffe, L.M.* ; Gao, P.* ; Wood, A.M.* ; Burgess, S.L.* ; Freitag, D.F.* ; Pennells, L.* ; Peters, S.A.* ; Hart, C.L.* ; Håheim, L.L.* ; Gillum, R.F.* ; Nordestgaard, B.G.* ; Psaty, B.M.* ; Yeap, B.B.* ; Knuiman, M.W.* ; Nietert, P.J.* ; Kauhanen, J.* ; Salonen, J.T.* ; Kuller, L.H.* ; Simons, L.A.* ; van der Schouw, Y.T.* ; Barrett-Connor, E.* ; Selmer, R.* ; Crespo, C.J.* ; Rodriguez, B.* ; Verschuren, W.M.* ; Salomaa, V.* ; Svärdsudd, K.* ; van der Harst, P.* ; Björkelund, C.* ; Wilhelmsen, L.* ; Wallace, R.B.* ; Brenner, H.* ; Amouyel, P.* ; Barr, E.L.* ; Iso, H.* ; Onat, A.* ; Trevisan, M.* ; D'Agostino, R.B.* ; Cooper, C.* ; Kavousi, M.* ; Welin, L.* ; Roussel, R.* ; Hu, F.B.* ; Sato, S.* ; Davidson, K.W.* ; Howard, B.V.* ; Leening, M.* ; Rosengren, A.* ; Dörr, M.* ; Deeg, D.J.* ; Kiechl, S.* ; Stehouwer, C.D.* ; Nissinen, A.* ; Giampaoli, S.* ; Donfrancesco, C.* ; Kromhout, D.* ; Price, J.F.* ; Peters, A. ; Meade, T.W.* ; Casiglia, E.* ; Lawlor, D.A.* ; Gallacher, J.* ; Nagel, D.* ; Franco, O.H.* ; Assmann, G.* ; Dagenais, G.R.* ; Jukema, J.W.* ; Sundström, J.* ; Woodward, M.* ; Brunner, E.J.* ; Khaw, K.T.* ; Wareham, N.J.* ; Whitsel, E.A.* ; Njølstad, I.* ; Hedblad, B.* ; Wassertheil-Smoller, S.* ; Engström, G.* ; Rosamond, W.D.* ; Selvin, E.* ; Sattar, N.* ; Thompson, S.G.* ; Danesh, J.*): Association of cardiometabolic multimorbidity with mortality. JAMA 314, 52-60 (2015)
13.
Gaulton, K.J.* et al.: Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47, 1415-1425 (2015)
14.
Holmes, M.V.* et al.: Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36, 539-550 (2015)
15.
Mons, U.* et al.: Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: Meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ 350:h1551 (2015)
16.
Müezzinler, A.* et al.: Smoking and all-cause mortality in older adults: Results from the CHANCES consortium. Am. J. Prev. Med. 49, e53–e63 (2015)
17.
Swerdlow, D.I.* et al.: HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials. Lancet 385, 351-361 (2015)
18.
Emerging Risk Factors Collaboration (Meisinger, C.) et al.: Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 311, 1225-1233 (2014)
19.
Yoneyama, S.* et al.: Gene-centric meta-analyses for central adiposity traits in up to 57412 individuals of European descent confirm known loci and reveal several novel associations. Hum. Mol. Genet. 23, 2498-2510 (2014)
20.
den Hoed, M.* et al.: Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat. Genet. 45, 621-631 (2013)